resveratrol has been researched along with decitabine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bess, MA; Chauhan, J; Clouser, CL; Dimick-Gray, S; Mansky, LM; Patterson, SE; van Oploo, JL; Zhou, D | 1 |
| Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J | 1 |
| Capalash, N; Parashar, G; Parashar, NC | 1 |
| Clarke, K; Qin, W; Sauter, ER; Weiland, T; Zhang, K | 1 |
| Glasow, A; Kortmann, RD; Menzel, F; Patties, I | 1 |
| Babaei Khorzoughi, R; Hosseini, H; Izadi, P; Koushki, M; Meshkani, R; Namvarjah, F; Shabani, M; Teimouri, M | 1 |
6 other study(ies) available for resveratrol and decitabine
| Article | Year |
|---|---|
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine.
Topics: Anti-HIV Agents; Azacitidine; Decitabine; Dose-Response Relationship, Drug; Drug Synergism; HIV-1; Humans; Molecular Structure; Resveratrol; Stilbenes | 2012 |
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship | 2016 |
Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.
Topics: Azacitidine; Base Sequence; Cell Line, Tumor; Cell Survival; Curcumin; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Cytosine Methylases; DNA, Complementary; Epigenesis, Genetic; Fanconi Anemia Complementation Group F Protein; Humans; Inhibitory Concentration 50; Promoter Regions, Genetic; Resveratrol; Sequence Analysis, DNA; Stilbenes; Transcription, Genetic | 2012 |
Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue.
Topics: Animals; Azacitidine; Breast; Breast Neoplasms; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Down-Regulation; Estrogens; Female; MicroRNAs; Rats; Rats, Inbred ACI; Resveratrol; Stilbenes | 2014 |
Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Combined Modality Therapy; Decitabine; Dideoxynucleosides; Epigenesis, Genetic; Humans; Hydroxamic Acids; Medulloblastoma; Mice; Neurogenesis; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Treatment Outcome; Tretinoin; Valproic Acid; Vorinostat; Xenograft Model Antitumor Assays | 2016 |
Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway.
Topics: Animals; Antioxidants; Decitabine; Diet, High-Fat; Disease Models, Animal; Epigenesis, Genetic; Hep G2 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Lipogenesis; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Random Allocation; Resveratrol; Signal Transduction | 2020 |